跳至主要内容
临床试验/NCT04785391
NCT04785391Unknown不适用

A Sample Collection Study to Validate the NEPHROCLEAR™ CCL14 Test

Astute Medical, Inc.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2021年6月8日最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
Persistent Severe Acute Kidney Injury as Determined by Physician Adjudication

研究概览

简要总结

The objective of this sample collection study is to collect urine samples to validate the NEPHROCLEAR™ CCL14 Test in patients with KDIGO stage 2 or 3 AKI. This study is observational and will have no impact on the medical management of the subject.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females 21 years of age or older;
  • Receiving care in an intensive care unit;
  • Expected to remain in the ICU for at least 48 hours after enrollment;
  • Use of indwelling urinary catheter as standard care at the time of enrollment;
  • Subject must have acute kidney injury (KDIGO Stage 2 or Stage 3) at the time of sample collection;
  • Urine sample must be collected within 36 hours of meeting KDIGO Stage 2 criteria;
  • Written informed consent provided by patient or legally authorized representative (LAR).

排除标准

  • Prior kidney transplantation;
  • Comfort-measures-only status;
  • Already receiving dialysis (either acute or chronic) or in imminent need of dialysis at the time of enrollment;
  • Known infection with human immunodeficiency virus (HIV) or active hepatitis (acute or chronic);
  • Special populations, pregnant women, prisoners or institutionalized individuals.

结局指标

主要结局

Persistent Severe Acute Kidney Injury as Determined by Physician Adjudication

时间窗: Within 5 days

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验